Fred Alger Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Fred Alger Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-438,619	Closed	-$2.68M	–	574
2021 Q3	$2.68M	Buy	+438,619	New	+$2.73M	0.01%	330
2017 Q4	–	Sell	-10,000	Closed	-$242K	–	607
2017 Q3	$242K	Buy	+10,000	New	+$235K	﹤0.01%	377
2016 Q4	–	Sell	-10,000	Closed	-$195K	–	537
2016 Q3	$195K	Buy	+10,000	New	+$169K	﹤0.01%	375

Fred Alger Management's FLXN Position: Q4 2021 in Review

Fred Alger Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 438,619 shares — an estimated $2.68M sold.

Fred Alger Management first reported a position in FLXN in Q3 2016 and held it in 3 quarters. The position peaked at $2.68M in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Fred Alger Management reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Fred Alger Management sold 438,619 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $2.68M.
Fred Alger Management first reported a position in Flexion Therapeutics, Inc. in Q3 2016 and held it in 3 quarters.
Fred Alger Management's Flexion Therapeutics, Inc. position peaked at $2.68M in Q3 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Fred Alger Management's 13F filing for Q4 2021, filed 14 Feb 2022.